Commercial Physical & Biological Research
Stocks Ranked by
Number of Employees

Filters
IQV stock icon
IQVIA
IQV
1
87,000
Employees
Market cap$41.3B
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
11%
upside
18 forecasts
Learn more
CRL stock icon
Charles River Laboratories
CRL
2
21,400
Employees
Market cap$11.7B
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
11%
upside
11 forecasts
Learn more
MEDP stock icon
Medpace
MEDP
3
5,900
Employees
Market cap$11.6B
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
4%
upside
6 forecasts
Learn more
INCY stock icon
Incyte
INCY
4
2,524
Employees
Market cap$11.9B
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
40%
upside
19 forecasts
Learn more
NOTV stock icon
Inotiv
NOTV
5
2,055
Employees
Market cap$121M
0
Funds
holding %
Analysts
bullish %
Learn more
SNCE
Science 37 Holdings
SNCE
6
460
Employees
Market cap$34.7M
0
Funds
holding %
Analysts
bullish %
Learn more
NRC stock icon
National Research Corp
NRC
7
435
Employees
Market cap$784M
0
Funds
holding %
Analysts
bullish %
Learn more
LUNA stock icon
Luna Innovations
LUNA
8
344
Employees
Market cap$97.2M
0
Funds
holding %
Analysts
bullish %
Learn more
ABSI stock icon
Absci
ABSI
9
156
Employees
Market cap$561M
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
45%
upside
9 forecasts
Learn more
MXCT stock icon
MaxCyte
MXCT
10
143
Employees
Market cap$404M
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
123%
upside
3 forecasts
Learn more
OABI stock icon
OmniAb
OABI
11
106
Employees
Market cap$538M
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
92%
upside
5 forecasts
Learn more
BIAF stock icon
bioAffinity Technologies
BIAF
12
75
Employees
Market cap$32.1M
0
Funds
holding %
Analysts
bullish %
Learn more
ISPC stock icon
iSpecimen
ISPC
13
53
Employees
Market cap$3.83M
0
Funds
holding %
Analysts
bullish %
Learn more
ONMD
OneMedNet
ONMD
14
20
Employees
Market cap$15.5M
0
Funds
holding %
Analysts
bullish %
Learn more
FOXO
FOXO Technologies
FOXO
15
15
Employees
Market cap$2.48M
0
Funds
holding %
Analysts
bullish %
Learn more